Small Molecule Drugs – medicarereport.org

Friday, December 5, 2025

Latest:

CMS FDA Health Care Finance Medicare - General Part D/Prescription Drugs

Eileen Cook April 18, 2025April 18, 2025 CMS, FDA, Healthcare Costs, Healthcare Finance, medicare, Medicare Drug Price Negotiation Program, Medicare Part D, Small Molecule Drugs

The Effect of Delaying the Selection of Small Molecule Drugs for Medicare Drug Price Negotiation

(By Juliette Cubanski and Tricia Neuman for The Kaiser Family Foundation Published: Apr 16, 2025) President Trump has just signed